Antibiotice SA 2019 Sustainability Report
The report details Antibiotice SA's sustainability performance for 2019, focusing on its role as Romania's leading generic medicine manufacturer. Key highlights include the launch of 10 new products, maintaining world leadership in Nystatin production, and achieving a 10% reduction in total energy consumption. The company emphasized its commitment to ethics through zero corruption incidents and supported the community via blood donation campaigns and educational scholarships. Environmental efforts were marked by a 60% recycling rate for product packaging and the transition to ISO 45001 for occupational health and safety.
Company: Antibiotice SA
Sector: Manufacturing
Country: Romania
Year: 2019
Type: Sustainability Report
Pages: 76
Back to company
Antibiotice SA
Non-Financial Report
The report details Antibiotice SA's sustainability performance for 2019, focusing on its role as Romania's leading generic medicine manufacturer. Key highlights include the launch of 10 new products, maintaining world leadership in Nystatin production, and achieving a 10% reduction in total energy consumption. The company emphasized its commitment to ethics through zero corruption incidents and supported the community via blood donation campaigns and educational scholarships. Environmental efforts were marked by a 60% recycling rate for product packaging and the transition to ISO 45001 for occupational health and safety.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 1, 2019 - Dec 31, 2019
Fiscal Year
2019
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees